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White matter (WM) strokes account for up to 30% of 
all stroke subtypes leading to permanent and progres-
sive cognitive and motor impairments (1). Unlike large 
artery strokes, these lesions encompass small infarcts in 
deep penetrating blood vessels in the subcortical brain. 
The main components of the WM are long extensions 
of myelinated axons that are organized into tracts and 
surrounded by oligodendrocytes and astrocytes. These 
cells are in state of close metabolomic co- dependence; 
damage to these structures leads to local activation of 
astrocytes and microglia, loss of oligodendrocytes, and 
axonal demyelination (2). Myelin is fundamental for 
metabolic support, structural integrity, and neural func-
tion; its absence increases the axons’ vulnerability to 
degeneration and progressive WM lesions. As a result, 
WM lesions may cause gait abnormalities and cognitive 
decline over time that present as vascular dementia. To 
date, there is no therapy that enhances the brain's own 
ability to regenerate damaged brain circuits. Cell- based 
therapies are emerging experimental strategies to re-
store brain function after stroke. Despite great promise, 
experimental efforts almost exclusively focused on re-
placing neural cells to enhance brain regeneration and 
neglected the therapeutic potential of glial cells (3, 4). 
However, there is increasing evidence that accelerating 
remyelination supports axonal integrity and prevents 
neural loss in experimental models of central nervous 
system (CNS) injury (5). A promising strategy to pro-
mote remyelination is the transplantation of immature 
glia. Astrocytes are known to promote oligodendrocyte 
progenitor cell production and maturation in brain de-
velopment and following CNS lesions (6). Furthermore, 
ablation of astrocytes has been reported to impair neu-
rovascular remodeling in stroke (7). Glial progenitors 
have been recently transplanted in for example spinal 
cord injury models and multiple sclerosis with promis-
ing results. Writing in Science Translational Medicine, 
Llorente et al. test the hypothesis that induced pluripo-
tent stem cell (iPSC)- derived glial progenitor cells pro-
mote functional repair in a mouse model of subcortical 
WM stroke (Figure 1) (8).
The work has two important implications. First, 
the study describes a rapid and efficient protocol to 
differentiate iPSC- derived neural progenitor cells 
(NPCs) toward glial- enriched progenitors (GEP). 
Building on previous work (9), Llorente et al. expose 
the cells to HIF activation using deferoxamine (DFX) 
to permanently direct the differentiation toward glia. 
Transcriptional analysis confirmed a successful in-
duction of GEP upon HIF activation by upregulation 
of glial- specific genes (e.g., CD44, S100A10, NFIX). 
Differentiation of GEP under this protocol resulted in 
a considerable increase for markers of the astrocyte- 
lineage (60% GFAP, 85% S100b, 0% DCX, 0% NeuN), 
whereas control NPCs without astrocytic differentia-
tion bias, preferentially expressed neural markers (45% 
DCX, 25% NeuN, 0% GFAP, 0% S100b), 4 months fol-
lowing cell transplantation.
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Transplantation of glial enriched progenitors provides therapeutic effects on 
axonal damage, cognitive and motor function following white matter stroke.
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Second, the study describes the regenerative poten-
tial of GEPs following transplantation in a mouse model 
of WM stroke. The expansion of WM strokes typically 
results in permanent astrocyte and oligodendrocyte 
damage and is associated with the degeneration of demy-
elinated axons. Deficits in motor and memory function 
could be observed up to 4 months after injury. To test 
the beneficial effects of GEPs, these cells were injected 
into the brains of mice at a subacute time period after 
stroke induction to recapitulate human disease presen-
tation. Months after transplantation, GEPs migrated to 
the contralateral WM, striatum, and cortex, and addi-
tionally displayed a higher proliferation rate compared 
with control NPCs, which were not found to leave the 
injury site.
After 2 and 4  months >50% of GEPs differentiated 
into adult astrocytes (GFAP+, S100b+), whereas most 
NPCs remained in an immature state (DCX+ NeuN– ). 
Both NPCs and GEPs foster axonal projections in the 
injured brain regions. In addition, transplanted GEPs re-
stored lost myelin around the infarct site, associated with 
the increase of mature oligodendrocytes. To determine 
functional recovery, motor and cognitive functions were 
tested at regular intervals using standard behavioral 
tests (grid walk, cylinder test, novel object recognition). 
Motor control was improved more substantially follow-
ing GEP transplantation compared with mice receiving 
NPCs. Similar effects were also observed in the cognitive 
tests; only GEP- treated mice revealed cognitive improve-
ments 4 months after injury.
To understand the casual relationship between the 
transplanted cells and improved functional recovery, 
Llorente et al. chemogenetically ablated the grafted 
NPCs and GEPs. Interestingly, NPC ablation partially 
worsened motor recovery, whereas GEP ablation did not 
alter functional recovery. These findings suggest that 
unlike NPCs, GEPs initiate local repair responses and 
are not required to maintain the recovered function.
To understand these mechanisms of WM repair, gene 
expression profiles of NPCs and GEPs were compared 
in an in vitro system. Transcriptional profiling of GEP 
revealed key molecular and cellular pathways enriched 
for a prorepair astrocytic phenotype for up to 4 months. 
Among others, genes driving myelination (e.g., LGALS2, 
SPHK1, ERG2) and neuroprotection (S100A10, GDF15) 
were enriched in hiPSC- GEPs. Most relevant released 
growth factors that may be involved during WM repair 
were FGF2, CXCL1, and VEGF.
There are two major limitations to this study. First, 
the use of immunocompromised mice may likely have 
had an impact on the endogenous response to WM 
stroke. While necessary for the context in this study, 
the authors suggest that future studies should opt for 
the use of engineered GEP lines that are able to avoid 
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rejection and be used as an allogenic cell- based ther-
apy for stroke. Second, and more importantly, the ef-
fect of hiPSC- GEP transplantation in aged animals, 
at distinct time points other than this study, variable 
sites of injection, and lastly different doses must still 
be determined. Carrying out further experiments to 
address this knowledge gap will prove to be vital in the 
quest for the clinical translation of such a novel stem 
cell therapy.
Overall, Llorente et al. reported that a one- time in-
jection of GEPs limits the progression of WM stroke 
and improves motor and cognitive function in mice, 
thereby providing a renewable and scalable cell source 
for therapeutics and research (Figure 1). Despite their 
immense therapeutic potential, first generation of cell 
therapies has previously revealed major drawbacks with 
variable clinical data and some safety concerns. Results 
contributed by high- quality basic research – like the 
study from Llorente et al. – provide supportive evidence 
that cell- based approaches can be developed into next- 
generation therapies for brain injury. However, major 
hurdles (e.g., immune incompatibilities, scaling to clini-
cal manufacturing of the cells) have to be overcome and 
given the heterogeneity of stroke pathology, different 
cell sources have to be tested. Only then will it be pos-
sible to offer clinically useful strategies that provide 
stroke patients with substantial improvements of their 
quality of life.
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